• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Cipla`s Generics Sodium Thiosulfate Receives Tentative Approval in US

    FDA

    Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement

    PR NEWSWIRE

    FDA Issues Reminder of Non-Substitution of PEDMARK for Pediatric Patients

    GLOBENEWSWIRE

    Fennec Pharmaceuticals` Pedmarqsi (sodium thiosulfate) Receives Approval in Europe

    EMA

    Fennec Announces European Commission Marketing Authorization for Pedmarqsi

    BIOSPACE

    Fennec Announces European Commission Marketing Authorization for Pedmarqsi

    GLOBENEWSWIRE

    Fennec Pharmaceuticals` Pedmarqsi (sodium thiosulfate) Receives Approval in the Europe

    EMA

    Fennec Pharma Receives Positive CHMP Opinion for (sodium thiosulfate)

    GLOBENEWSWIRE

    FDA Grants Orphan Drug to Pedmark Injection for Prevention of Ototoxicity

    ONCLIVE

    Fennec Pharma Announces PEDMARK Receives Orphan Drug Exclusivity from FDA

    GLOBENEWSWIRE

    FDA Confirms Paragraph IV Patent Litigation for Sodium Thiosulfate Intravenous Injection

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Aprepitant, Azilsartan, Bupivacaine, Cladribine, Elrombopag, Fosnetupitant, Fostamatinib, Ivacaftor and Sodium Thiosulfate.

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Sodium Thiosulfate

    FDA

    Fennec Pharmaceuticals Announces Management Change

    GLOBENEWSWIRE

    Fennec preps for second CRL for potential hearing loss drug

    ENDPTS

    JCB Laboratories Receives Form 483

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.